Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.


Journal

AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 11 9 2018
medline: 30 1 2020
entrez: 11 9 2018
Statut: ppublish

Résumé

Much has been learnt from the functions of host restriction factors during acute and chronic HIV-1 infection, but far less is known about their role in HIV-1-infected individuals in which viral load is stably suppressed with antiretroviral therapy (ART). In this study transcriptional expression of 42 host restriction factors was determined for memory CD4+ T cells sorted from 10 uninfected and 21 HIV-1-infected individuals, treated with suppressive ART and for which the viral reservoir was quantified. No significant associations were observed between restriction factor expression and HIV-1 reservoir size, quantified by measurement of HIV-1 Gag DNA using droplet digital polymerase chain reaction, and by measurement of replication-competent inducible virus using quantitative viral outgrowth assays. Expression of eight of the restriction factors differed significantly, and with a false discovery rate of <10%, between ART-suppressed and uninfected individuals. APOBEC3G, ISG15, LGALS3BP, RNASEL, and MX2 were upregulated in the ART-suppressed individuals, likely because of increased levels of immune activation observed in virally suppressed compared with uninfected individuals. In contrast CDKN1A, TRIM11, and BRD4 were expressed at lower levels in ART-suppressed than uninfected individuals. This suggests perturbation of the CD4+ memory T cell compartment, in which a viral reservoir persists in HIV-1-infected individuals with effective ART. Modulation of restriction factor expression, or overrepresentation of cell subsets that intrinsically express these restriction factors at lower levels could result in the distinct expression of restriction factors observed in treated infected individuals.

Identifiants

pubmed: 30198299
doi: 10.1089/AID.2018.0162
pmc: PMC6343196
doi:

Substances chimiques

Anti-Retroviral Agents 0
Immunologic Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-111

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI126617
Pays : United States

Références

Curr HIV/AIDS Rep. 2017 Jun;14(3):93-100
pubmed: 28434169
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
PLoS Pathog. 2013;9(5):e1003398
pubmed: 23737751
J Clin Invest. 2018 Feb 1;128(2):876-889
pubmed: 29355843
Cell Host Microbe. 2014 Jun 11;15(6):717-728
pubmed: 24922574
Retrovirology. 2013 Oct 16;10:106
pubmed: 24131498
J Virol. 2013 Nov;87(21):11924-9
pubmed: 23966394
AIDS. 2015 Feb 20;29(4):411-20
pubmed: 25602681

Auteurs

Nathaniel D Bachtel (ND)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Greta A Beckerle (GA)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Talia M Mota (TM)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Miguel de Mulder Rougvie (MM)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Rui André Saraiva Raposo (RAS)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

R Brad Jones (RB)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Douglas F Nixon (DF)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Richard Apps (R)

Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University , Washington, District of Columbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH